摘要:
The present invention relates to a multiplexer/demultiplexer for use in mobile communication devices and provides a small and low-loss multiplexer/demultiplexer. The present invention provides a multiplexer/demultiplexer including a first to a third ports each externally terminated with a pure resistance, in which the second port is made to be a common port by connecting between the first port and the ground a first resonant circuit which makes serial resonance at a frequency within a first frequency band or in its proximity, and further connecting an inductive element in series between the first port and the second port, and connecting between the third port and the ground a second resonant circuit which makes serial resonance at a frequency within a second frequency band which is different from the first frequency band or in its proximity, and further connecting a capacitive element in series between the third port and the second port.
摘要:
An antenna switching device of the present invention includes: a transmitting terminal for receiving a transmitting signal; a first antenna terminal connected to a first antenna; a second antenna terminal connected to a second antenna; a receiving terminal for outputting receiving signals received at the first antenna terminal and the second antenna terminal; a selecting unit for selecting one mode among a first mode for outputting a signal corresponding to the transmitting signal to the first antenna terminal, a second mode for outputting the receiving signal received at the first antenna to the receiving terminal, and a third mode for outputting the receiving signal received at the second antenna to the receiving terminal.
摘要:
A laminated filter includes: a first dielectric layer having a first shield electrode on one principal plane; a second dielectric layer having resonator electrodes on one principal plane; a third dielectric layer having a coupling electrode provided facing part of the above-described resonator electrodes; a fourth dielectric layer having a second shield electrode on one principal plane; a fifth dielectric layer whose at least one principal plane is exposed outside; and a grounding electrode provided on the other principal plane of the above-described dielectric layer and/or the above-described one principal plane of the above-described fifth dielectric layer, and the above-described first grounding electrode and the above-described first shield electrode are electrically connected through a via hole provided in the above-described first dielectric layer.
摘要:
A clear color image having a high contrast ratio without particular coloration is displayed on a screen by improved display apparatus. Such display apparatus is comprised of a spatial light modulator including a photo-conductive layer, a photo-modulator layer and a dielectric mirror, a device for writing color images of different colors onto the spatial light modulator time-divisionally in a sequence of the different colors, a reading device for producing reading lights having different colors in synchronism with time-divisional writing of the color images, and for projecting the reading lights to the spatial light modulator, a driving device for supplying the spatial light modulator with different voltages and frequencies correspondingly with the reading light of different colors and in synchronism with time-divisional projections of the reading lights, and a device for projecting the color images read out from the spatial light modulator on the display device.The dielectric mirror may have a light absorbance characteristic controlled to be wavelength-selective to absorb a color of light to which the photo-conductive layer is most sensitive, so that lights having different colors leaked into the photo-conductive layer through the dielectric mirror are controlled to cause a uniform impedance of the photo-conductive layer.
摘要:
The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y-Z- represents —O—CR3═N— (wherein R3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1 represents —NR10R11 (wherein R10 and R11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2 represents —NR13R14 (wherein R13 and R14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供了包含作为活性成分的式(I)所示的嘧啶衍生物的抗肿瘤剂等:其中-XYZ-表示-O-CR3-N-(其中R3表示氢原子, 取代或未取代的芳族杂环基等)等,R 1表示-NR 10 R 11(其中R 10和R 11可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等)等, R 2表示-NR 13 R 14(其中R 13和R 14可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等)]或其药学上可接受的盐。
摘要:
[wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(═O)—, —SO2—, —OC(═O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like]Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided. These have anti-inflammatory activities or modulation activities on the functions of TARC and/or MDC and are useful for treating and/or preventing a disease which is related to T cells, such as an allergic disease, an autoimmune disease or transplant rejection.
摘要翻译:[其中m和n可以相同或不同,并且各自表示1〜3的整数,其中m + n为4以下; R 1表示-NR 4 R 5(其中R 4,R 5和R 5) 可以相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的芳烷基等); R 2表示上述式(II),式(IV)等; A表示单键,-C(-O) - , - SO 2 - , - OC(-O) - 等; 和R 3表示取代或未取代的低级烷基,取代或未取代的环烷基,取代或未取代的芳烷基等〕由上式(I)表示的双环嘧啶衍生物或其季铵盐或药学上可接受的盐 可接受的盐等。 它们具有对TARC和/或MDC的功能的抗炎活性或调节活性,并且可用于治疗和/或预防与T细胞相关的疾病,例如过敏性疾病,自身免疫疾病或移植排斥反应。
摘要:
[wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(═O)—, —SO2—, —OC(═O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like] Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided. These have anti-inflammatory activities or modulation activities on the functions of TARC and/or MDC and are useful for treating and/or preventing a disease which is related to T cells, such as an allergic disease, an autoimmune disease or transplant rejection.
摘要:
The present invention provides an agent for prevention and/or treatment of itching comprising a substance capable of suppressing the function involved in signal transduction of GPR4 as an active ingredient. It also provides a nitrogen-containing tricyclic compound represented by the formula (I) or a quaternary ammonium salt thereof, or a pharmaceutically acceptable salt thereof; [wherein R1 represents substituted or unsubstituted lower alkyl, etc.; R2 represents hydrogen, substituted or unsubstituted lower alkyl, etc.; R3 and R4 are the same or different and each represents hydrogen, lower alkyl, etc.; n represents 0 or 1; X represents —(CH2)2—, etc.; and Y represents the formula (II); (wherein W represents CH or a nitrogen atom; Z1 and Z2 are the same or different and each represents hydrogen, substituted or unsubstituted lower alkyl, etc.; and Z3 represents hydrogen, substituted or unsubstituted lower alkyl, etc.)]
摘要翻译:本发明提供了用于预防和/或治疗瘙痒的药剂,其包含能够抑制作为活性成分的GPR4的信号转导所涉及的功能的物质。 它还提供由式(I)表示的含氮三环化合物或其季铵盐或其药学上可接受的盐; [其中R 1表示取代或未取代的低级烷基等; R 2表示氢,取代或未取代的低级烷基等; R 3和R 4相同或不同,各自表示氢,低级烷基等; n表示0或1; X表示 - (CH 2 2)2 - 等; Y表示式(II); (其中W表示CH或氮原子; Z 1和Z 2相同或不同,各自表示氢,取代或未取代的低级烷基等; Z 代表氢,取代或未取代的低级烷基等)]
摘要:
The present invention provides a method for producing an indazol-3-ylmethyl phosphonium salt represented by Formula (IV): [wherein X represents halogen, OSO2Ra (wherein Ra represents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like), or OC(═O)Rb (wherein Rb has the same meaning as the above Ra), or the like, and R1, R2 and R3 may be the same or different and each represents substituted or unsubstituted aryl or the like] or a salt thereof, which comprises reacting a compound represented by Formula (I): a compound represented by Formula (II): H—X (II) (wherein X has the same meaning as defined above), and a compound represented by Formula (III): (wherein R1, R2 and R3 have the same meanings as defined above, respectively), and the like.
摘要:
The present invention provides a compound represented by formula (I): [wherein X—Y-Z represents R5N—C═O (wherein R5 represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl, substituted or unsubstituted lower alkenyl, or substituted or unsubstituted lower alkynyl), etc; R1 and R2 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc; and R3 and R4 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, etc], or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供由式(I)表示的化合物:[其中XYZ表示R 5 NCO(其中R 5表示氢原子,取代或未取代的低级烷基,取代的 或未取代的芳烷基,取代或未取代的低级烯基,或取代或未取代的低级炔基)等; R 1和R 2可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等; R 3和R 4可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等]或其药学上可接受的盐。